Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Acad Pediatr. 2015 Jan-Feb;15(1):77–81. doi: 10.1016/j.acap.2014.06.008

Table 1.

Characteristics of Children with Bronchiolitis on the Ward, According to Clinical Course

Characteristics No intensive
care use
(n=1,715)
Late intensive
care use
(n=47)
P-value
Study year 0.12
  2007–2008 winter season 21% 30%
  2008–2009 winter season 39% 26%
  2009–2010 winter season 40% 44%
Age, mo 0.04
  <6 62% 77%
  ≥6 38% 23%
Sex 0.77
  Male 60% 57%
  Female 40% 43%
Race 0.59
  White 60% 55%
  Black 26% 26%
  Other or missing 14% 19%
Hispanic ethnicity 37% 40% 0.61
Gestational age, weeks 0.20
  <32 7% 13%
  32–36.9 17% 17%
  ≥37 77% 70%
Birth weight, pounds 0.07
  <5 12% 21%
  ≥5 88% 79%
Exposure to tobacco smoke 13% 17% 0.39
Major relevant, comorbid medical disorder* 21% 24% 0.66
Previously admitted overnight to a hospital (any cause) 20% 30% 0.10
Kept in ICU, premature nursery, or any type of special care facility when born (%) 25% 36% 0.09
When difficulty breathing began prior to index visit 0.11
  <24 hours or no difficulty breathing 29% 38%
  1–3 days 43% 47%
  ≥4 days 28% 15%
Vital signs on first day of admission
  Highest respiratory rate, per minute (median, IQR) 52 (44–60) 56 (48–70) 0.003
    <70 92% 70% <0.001
    ≥70 8% 30%
  Lowest O2 saturation on room air, % (median, IQR) 94 (92–96) 91 (87–95) 0.003
Given nebulized albuterol on first day of admission 34% 55% 0.003
Given nebulized epinephrine on first day of admission 7% 19% 0.01
Given steroids on first day of admission 15% 21% 0.28
Received high flow oxygen on first day of admission 2% 21% <0.001
Virology results of nasopharyngeal aspirate
  RSV 72% 72% 0.95
  HRV 25% 28% 0.71
  Adenovirus 8% 11% 0.59
  HMPV 8% 9% 0.78
Number of viral pathogens detected from nasopharyngeal aspirate 1.00
  0 5% 4%
  1 65% 66%
  ≥2 30% 30%

Abbreviations: IQR, interquartile range; ICU, intensive care unit; RSV, respiratory syncytial virus; HRV, human rhinovirus; HMPV, human metapneumovirus.

*

Relevant comorbid medical disorders include respiratory, cardiac, neurologic, gastrointestinal, and immunologic diseases.

Data are available for 1401 patients.

Percentages do not sum up to 100% because of co-infections.